Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT03528980
Active, not recruiting Observational

Impact of Weight Loss Induced by Bariatric Surgery or Nutritional Management on Sexual Function in Men With Severe Obesity

NCT03528980 · tracked via the Priya Life Science France tracker
Sponsor
University Hospital, Lille
Phase
Observational
Started
2012-05-21
Last updated
2026-05-18

Condition(s) studied

ObesityBariatric Surgery Candidate

Study summary

Study of the impact of weight loss induced by surgery (interventional group) or optimal nutritional management (control group) on sexual function in men with severe obesity

Eligibility

Sex
MALE
Min age
18 Years
Max age
55 Years
Healthy volunteers
No
Inclusion Criteria: * Severe obesity with BMI\> 25 kg / m2 Exclusion Criteria: * Patient having undergone sterilization

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
Chu de Caen Normandie Caen France
CHRU, Hôpital Claude Huriez Lille France
Chu Rouen Rouen France

More University Hospital, Lille trials in France

Von Willebrand Factor Point-of-care Testing to Improve Minimally Invasive TAVI Outcomes Recruiting
Neoadjuvant Hypofractionated Stereotactic Body Radiation Therapy Prior to Surgery for Hepatocellular Carcinoma: a Feasibility Study. Recruiting
PAGETEX® Photodynamic Therapy Device for the Treatment of Extra Mammary Paget's Disease of the Vulva (EMPV). Recruiting
Perinatal Covid-19 Infection, NO Pathway, and Minipuberty Recruiting
Determinants of the Long-Term Success of Bariatric Surgery Recruiting

Other trials for the same condition

Effect of Agonist GLP1 on Adipose Tissue in Patients Undergoing Bariatric Surgery Recruiting
Endoscopic Sutured Gastroplasty with Endomina® Device Versus Standard of Care in Patients with Type 2 Diabetes and Class I Obesity: a Multi-center, Randomized Controlled Trial Recruiting
Evaluation of the Care Pathway Offered by the "Chronic Disease Unit" to Obese Patients Recruiting
Determinants of the Long-Term Success of Bariatric Surgery Recruiting
Prevalence, Determinants and Consequences of Dyspnea During Weaning in Critically Ill Obese Patients Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03528980 on ClinicalTrials.gov ↗ ← All trials in France